Génomic Vision SAの機関の所有権
Génomic Vision SAの機関の所有権は何ですか。
Génomic Vision SAの機関の所有権は8.59%です。
機関の所有権の定義は何ですか。
機関所有権は、ミューチュアル・ファンドまたは年金基金、保険会社、投資会社、その他の資金を管理する他の団体が所有する会社の株式数です。
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
EURONEXTのセクタHealth Careにおける機関の所有権の企業と比べるGénomic Vision SA
Génomic Vision SAは何をしますか。
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; and development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.
Génomic Vision SAと類似の機関の所有権
- Atlasの機関の所有権は8.56%です。
- Exore Resourcesの機関の所有権は8.56%です。
- Nath Bio-Genes (India)の機関の所有権は8.57%です。
- Whiteの機関の所有権は8.57%です。
- 92 Ltdの機関の所有権は8.57%です。
- Imugeneの機関の所有権は8.59%です。
- Génomic Vision SAの機関の所有権は8.59%です。
- Godrej Industriesの機関の所有権は8.59%です。
- Butterfly Gandhimathi Appliancesの機関の所有権は8.59%です。
- Delfingen Industry SAの機関の所有権は8.59%です。
- Solutiance AGの機関の所有権は8.60%です。
- Formycon AGの機関の所有権は8.60%です。
- Vox Royalty Corpの機関の所有権は8.60%です。